Skip to content
10-Q

Quarterly Report

CAPRICOR THERAPEUTICS, INC. CAPR

0001104659-25-109298

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 45.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 45.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 45.69M sh
Shares Diluted Q3 2025 · Sep 30, 2024 33.09M sh
Shares Diluted Q3 2025 · Sep 30, 2024 32.1M sh
Capex Q3 2025 · Sep 30, 2025 $1.24M
Capex Q3 2025 · Sep 30, 2024 $678.07K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$46.24M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$25.2M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $19.51M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $11.29M
Stockholders Equity Q3 2025 · Sep 30, 2025 $83.87M
Stockholders Equity Q3 2025 · Jun 30, 2025 $104.98M
Stockholders Equity Q3 2025 · Mar 31, 2025 $127.65M
Stockholders Equity Q3 2025 · Dec 31, 2024 $145.46M
Stockholders Equity Q3 2025 · Sep 30, 2024 $68.26M
Stockholders Equity Q3 2025 · Jun 30, 2024 $11.5M
Stockholders Equity Q3 2025 · Mar 31, 2024 $18.43M
Stockholders Equity Q3 2025 · Dec 31, 2023 $22.6M
Current Liabilities Q3 2025 · Sep 30, 2025 $28.15M
Current Liabilities Q3 2025 · Dec 31, 2024 $21.03M
Total Liabilities Q3 2025 · Sep 30, 2025 $42.57M
Total Liabilities Q3 2025 · Dec 31, 2024 $25.02M
Current Assets Q3 2025 · Sep 30, 2025 $100.95M
Current Assets Q3 2025 · Dec 31, 2024 $163.39M
Total Assets Q3 2025 · Sep 30, 2025 $126.44M
Total Assets Q3 2025 · Dec 31, 2024 $170.48M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.54
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.64
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.54
Eps Basic Q3 2025 · Sep 30, 2025 −$1.64
Eps Basic Q3 2025 · Sep 30, 2024 −$0.38
Eps Basic Q3 2025 · Sep 30, 2024 −$1.04
Sga Expense Q3 2025 · Sep 30, 2025 $5.92M
Sga Expense Q3 2025 · Sep 30, 2025 $17.66M
Sga Expense Q3 2025 · Sep 30, 2024 $3.46M
Sga Expense Q3 2025 · Sep 30, 2024 $10.59M
Rd Expense Q3 2025 · Sep 30, 2025 $20.36M
Rd Expense Q3 2025 · Sep 30, 2025 $61.32M
Rd Expense Q3 2025 · Sep 30, 2024 $11.81M
Rd Expense Q3 2025 · Sep 30, 2024 $35.41M
Net Income Q3 2025 · Sep 30, 2025 −$24.57M
Net Income Q3 2025 · Sep 30, 2025 −$74.87M
Net Income Q3 2025 · Jun 30, 2025 −$25.91M
Net Income Q3 2025 · Mar 31, 2025 −$24.39M
Net Income Q3 2025 · Sep 30, 2024 −$12.56M
Net Income Q3 2025 · Sep 30, 2024 −$33.35M
Net Income Q3 2025 · Jun 30, 2024 −$11M
Net Income Q3 2025 · Mar 31, 2024 −$9.79M
Operating Income Q3 2025 · Sep 30, 2025 −$26.28M
Operating Income Q3 2025 · Sep 30, 2025 −$78.99M
Operating Income Q3 2025 · Sep 30, 2024 −$13.01M
Operating Income Q3 2025 · Sep 30, 2024 −$34.87M
Revenue Q3 2025 · Sep 30, 2024 $2.26M
Revenue Q3 2025 · Sep 30, 2024 $11.14M